Part of the JLab endeavors in San Carlos CA, NAVAN Technologies describe what they do as engineering pipelines into cells - offering delivery of the User's chosen cargo into any cell. The firm is enabling next generation cellular engineering for therapeutics and regnerative medicine through seamless, direct delivery of any cargo into any cell without perturbing cell function or viability in the process.Management's vision is to facilitate cell and gene therapies at the point of care. With the capability to streamline new therapy development and robust performance at scale, NanoStraws significantly decrease costs, making clinical applications affordable and accessible. Based on technology exclusively licensed from Stanford University, the firm's novel, non-viral NanoStraw platform, technology provides direct intracellular access into hard-to-transfect human primary cells for the efficient delivery of any cargo into any cell. By using a physical, non-perturbative delivery mechanism (Nano-injection) for cell transformation, many of the challenges presented by viral-based cell manufacturing technology provides direct intracellular access into hard-to-transfect human primary cells for the efficient delivery of any cargo into any cell. By using a physical, non-perturbative delivery mechanism (Nano-injection) for cell transformation, many of the challenges presented by viral-based cell manufacturing are avoided while preserving cell function and viability.
